ArticleChest2021

Benefits of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers on Progression of Emphysema and Lung Function Decline.

Xander Bertels et al.PubMed ↗Publisher ↗

No numbers read from the abstract.